Articles by David Haen MF

  • Posted on 6/1/20

    Is Pfizer a Great Dividend Stock?

    Facing economic uncertainties or prolonged downturns, investors typically seek the safe haven of defensive stocks. Large multinational pharmaceutical companies fall into this category. Illness does not . . .

  • Posted on 5/11/20

    Is Axsome Therapeutics a Screaming Buy?

    The past few weeks have been quite busy for Axsome Therapeutics (NASDAQ:AXSM), notching two wins and one failure in late-stage clinical trials.On March 30, the company . . .

  • Posted on 5/4/20

    Did Merck Just Receive a Gift From the FDA?

    Receiving a diagnosis of cancer is scary. Undergoing treatment to fight the cancer can be just as frightening. Doing it in the midst of a global . . .

  • Posted on 4/22/20

    Could CVS Health Be a Millionaire-Maker Stock?

    The coronavirus pandemic thrust the entire healthcare system under a microscope. Now, daily news reports and conversations center around the number of hospital beds and ventilators, . . .

  • Posted on 4/13/20

    Better Buy: Alnylam Pharmaceuticals vs. Vir Biotechnology

    Alnylam Pharmaceuticals (NASDAQ:ALNY) and Vir Biotechnology (NASDAQ:VIR) show no signs of slowing despite the current economic climate. These well-capitalized biotechs have ambitious plans to develop an . . .

  • Posted on 4/8/20

    Is Quest Diagnostics a Great Dividend Stock?

    The current coronavirus pandemic has put the U.S. healthcare system under a microscope and emphasized the importance of diagnostic testing. Quest Diagnostics (NYSE:DGX), a leader in . . .

  • Posted on 2/20/20

    Better Buy: Vertex Pharmaceuticals vs. Incyte

    The core franchises of Vertex Pharmaceuticals (NASDAQ:VRTX) and Incyte (NASDAQ:INCY) continue to generate hefty sales, enabling the companies to invest heavily in exciting research and development . . .

  • Posted on 12/24/19

    These Were the 10 Best Healthcare Stocks of 2019

    Biotech, hands down, wins the race for out-performance in the healthcare sector. Delivering new, valuable medicines has proven to be a winning strategy, even if the . . .

  • Posted on 12/20/19

    Is Main Street Capital a Great Dividend Stock?

    Business development companies, or BDCs, help fuel the hundreds of thousands of small- and mid-sized businesses in the United States. These companies provide financing for businesses, . . .

  • Posted on 12/19/19

    Exact Sciences Should Benefit from Pfizer’s News Today

    This morning, Pfizer (NYSE:PFE) announced that the Food and Drug Administration granted priority review status to its supplemental New Drug Application (sNDA) for its Braftovi in . . .

  • Posted on 12/19/19

    Exact Sciences Should Benefit from Pfizer’s News Today

    This morning, Pfizer (NYSE:PFE) announced that the Food and Drug Administration granted priority review status to its supplemental New Drug Application (sNDA) for its Braftovi in . . .

  • Posted on 11/22/19

    Will Thermo Fisher Buy Qiagen?

    Qiagen (NYSE:QGEN) shareholders have had quite a ride recently. The stock price crashed $40 into the mid-$20s after the company forecast a slowdown in growth, citing . . .

  • Posted on 10/17/19

    Reata Pharmaceuticals Repositions Itself for Success

    It's been a busy October for Reata Pharmaceuticals (NASDAQ:RETA), which kicked things off Oct. 10 with the announcement that it would end its nine-year partnership with . . .